LOH, LST, and TAI Profiles in Solid Tumors Harboring Pathogenic or Likely Pathogenic BRCA1/2 Variants: An Exploratory Study
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27198851 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Suleyman Erdogdu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Aydin City Hospital, Efeler, Aydin 09020, Türkiye. Hauptthemen laut MEDLINE: Loss of Heterozygosity, BRCA2 Protein, BRCA1 Protein, Allelic Imbalance. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Homologous recombination deficiency (HRD) is a critical indicator of genomic instability; however, the composite HRD score may not reflect the distribution of distinct genomic scar components underlying this phenotype. In this exploratory study, we compared the absolute and relative contributions of loss of heterozygosity (LOH), large-scale state transitions (LST), and telomeric allelic imbalance (TAI) among solid tumors harboring pathogenic or likely pathogenic (P/LP) variants in BRCA1 or BRCA2. This retrospective study included 76 patients with solid tumors who underwent HRD testing between January 2023 and January 2026. P/LP variants in homologous recombination repair (HRR) genes, alongside LOH, LST, and TAI scores, were evaluated. The composite HRD score was calculated as LOH + LST + TAI, with values ≥ 56 defined as HRD-positive. Additionally, the relative contribution of each scar component to the total HRD score was determined. Given the small sizes of the BRCA1-only and BRCA2-only subgroups and the heterogeneity of the overall cohort, all gene-group comparisons were considered exploratory and hypothesis-generating. Overall, 21.1% of the cohort was HRD-positive. Patients harboring BRCA1/2 P/LP variants displayed a significantly higher median HRD score compared to non-carriers (47.0 vs. 30.0; p = 0.016). When comparing patients with tumors harboring BRCA1-only (n = 9) and BRCA2-only (n = 10) P/LP variants, LOH was higher in the BRCA2 group (19.0 vs. 5.0; p = 0.036); however, this difference did not retain statistical significance following false discovery rate (FDR) adjustment (q = 0.108). In an exploratory sensitivity analysis restricted to breast and ovarian tumors (BRCA1-only, n = 5; BRCA2-only, n = 9), the LOH/HRD ratio was higher in the BRCA2 group (0.301 vs. 0.000; p = 0.026; q = 0.039), whereas the LST/HRD ratio was higher in the BRCA1 group (0.488 vs. 0.310; p = 0.019; q = 0.039). These estimates were based on very small subgroups and should therefore be interpreted cautiously. This exploratory analysis identified differences in the relative distributions of LOH and LST between tumors harboring BRCA1-only and BRCA2-only P/LP variants, particularly in the breast/ovarian subset. However, the small and heterogeneous subgroups, together with the absence of systematic assessment of biallelic BRCA1/2 inactivation, preclude gene-specific or mechanistic conclusions. These observations should be regarded as hypothesis-generating and require validation in larger, tumor-specific, independent cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Aydin City Hospital, Efeler, Aydin 09020, Türkiye.
- Department of Medical Pathology, School of Medicine, Aydin Adnan Menderes University, Efeler, Aydin 09010, Türkiye.
- Department of Medical Genetics, School of Medicine, Aydin Adnan Menderes University, Efeler, Aydin 09010, Türkiye.
- Faculty of Engineering, Aydin Adnan Menderes University, Efeler, Aydin 09010, Türkiye.
ORCID-Profile: Busra Ekinci, Seda Orenay-Boyacioglu, Olcay Boyacioglu, Ibrahim Halil Erdogdu
Zitieren
APA
Erdogdu, S., Ekinci, B., Orenay-Boyacioglu, S., Boyacioglu, O., Erdogdu, I. H., & Meteoglu, I. (2026). LOH, LST, and TAI Profiles in Solid Tumors Harboring Pathogenic or Likely Pathogenic BRCA1/2 Variants: An Exploratory Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198851
Vancouver
Erdogdu S, Ekinci B, Orenay-Boyacioglu S, Boyacioglu O, Erdogdu IH, Meteoglu I. LOH, LST, and TAI Profiles in Solid Tumors Harboring Pathogenic or Likely Pathogenic BRCA1/2 Variants: An Exploratory Study. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198851
BibTeX
@article{Erdogdu2026,
author = {Erdogdu, Suleyman and Ekinci, Busra and Orenay-Boyacioglu, Seda and Boyacioglu, Olcay and Erdogdu, Ibrahim Halil and Meteoglu, Ibrahim},
title = {LOH, LST, and TAI Profiles in Solid Tumors Harboring Pathogenic or Likely Pathogenic BRCA1/2 Variants: An Exploratory Study},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27198851}
}
EUVIMED